ClinicalTrials.Veeva

Menu

Comparison of Intravenous Co-amoxiclav Versus Benzyl Penicillin

C

Combined Military Hospital, Pakistan

Status

Completed

Conditions

Tonsillitis Streptococcal

Treatments

Drug: inj co-amoxiclav 50 units/kg/day vs inj Benzyl Penicillin 25000 units/kg/day

Study type

Interventional

Funder types

Other

Identifiers

NCT04215770
CMH-01-2019

Details and patient eligibility

About

To compare intravenous Co-amoxiclav versus Benzyl penicillin in children with severe streptococcal tonsillitis in terms of efficacy, safety and cost effectiveness.

Full description

Efficacy was measured through improvement (decrease in fever, settling lymphadenopathy and disappearance of tonsillar exudate) in Centor Criteria score on daily basis. Improvement i.e reduction in Centor Criteria score was recorded for all children till full recovery.

Safety was measured by frequency of hypersensitivity reactions or severe side effects of antibiotics necessitating stoppage of the drug. All the children in both Groups were given test dose of the antibiotic before giving full dose of antibiotic prescribed.

Cost effectiveness was compared in terms of total cost of injections (Co-amoxiclav versus Benzyl penicillin) which were administered to children in both groups.

Enrollment

310 patients

Sex

All

Ages

5 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Children who had 3 or 4 score according to Centor Criteria for tonsillitis/pharyngotonsillitis, were included in study
  2. Children between ages of 5 to 15 years
  3. Children with positive Rapid Antigen detection Test (RADT) for Streptococcus Pyogenes

Exclusion criteria

  1. Immunocompromised children
  2. Children with known hypersensitivity to Penicillins (esp Coamoxiclav and Benzyl penicillin)
  3. Children with liver or renal failure
  4. Children who were already using any oral or parenteral antibiotics

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

310 participants in 2 patient groups

Inj Co-amoxiclav
Active Comparator group
Description:
Group A children were advised Inj Co-amoxiclav 50 units/kg/day in 3 divided doses daily
Treatment:
Drug: inj co-amoxiclav 50 units/kg/day vs inj Benzyl Penicillin 25000 units/kg/day
Inj Benzyl Penicillin
Active Comparator group
Description:
Group B patients were advised inj Benzyl Penicillin 25000 units/kg/day in 3 divided doses
Treatment:
Drug: inj co-amoxiclav 50 units/kg/day vs inj Benzyl Penicillin 25000 units/kg/day

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems